生物活性 | |||
---|---|---|---|
描述 | 5-HT2B antagonist-1, an orally active antagonist with an IC50 value of 33.4 nM, is applicable in diseases involving 5-HT2B receptor signaling, such as hepatocellular carcinoma, cardiovascular disease, or gastrointestinal disease[1][2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.25mL 0.45mL 0.22mL |
11.25mL 2.25mL 1.12mL |
22.49mL 4.50mL 2.25mL |
参考文献 |
---|